Misago D. Seth - Concepedia

Author

Misago D. Seth

National Institute for Medical Research ORCID

Also Known As

Bakari, Catherine, Ishengoma, Deus S., Juliano, Jonathan J., Lazaro, Samwel, M. Seth, Megan A. Seth, Misago D. Seth, Misago D Seth, Misago D. Seth, Misago Dimson Seth

Publications

678

Citations

H-Index

Concepts

All Affiliations

National Institute for Medical Research African Malaria Network Trust Monash University University of North Carolina at Chapel Hill Brown University

About

Misago D. Seth is an author at National Institute for Medical Research.

Misago D. Seth

Publications

543

Citations

H-Index

Page 1

	Year	Citations
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, The Lancet Infectious Diseases	2024	81
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania Jonathan J. Juliano, David Giesbrecht, Alfred Simkin,	2023	54
Community knowledge, attitude, practices and beliefs associated with persistence of malaria transmission in North-western and Southern regions of Tanzania Edwin Liheluka, Isolide S. Massawe, Mercy G. Chiduo, Malaria Journal	2023	44
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months John Lusingu, Samwel Gesase, Salum Msham, Malaria Journal	2009	41
Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania Bruno P. Mmbando, Method D Segeja, H.A. Msangeni, Malaria Journal	2009	39
Malaria Species Positivity Rates Among Symptomatic Individuals Across Regions of Differing Transmission Intensities in Mainland Tanzania Zachary R. Popkin-Hall, Misago D. Seth, Rashid A. Madebe, The Journal of Infectious Diseases	2023	39
Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021 Eric Rogier, Nastassia Battle, Catherine Bakari, Scientific Reports	2024	36
Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania Adam M. Fimbo, Omary Minzi, Bruno P. Mmbando, Journal of Clinical Medicine	2020	32
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, The Lancet Microbe	2024	31
High prevalence and risk of malaria among asymptomatic individuals from villages with high prevalence of artemisinin partial resistance in Kyerwa district of Kagera region, north-western Tanzania Salehe S. Mandai, Filbert Francis, Daniel P. Challe, Malaria Journal	2024	23

Page 1